Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-29

Clinical Trial Update: Analyzing the Pharmacodynamic Substances and the Effects of Yiqihuayu Decotion for Acute Ischemic Stroke (PHYSIS) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating pharmacodynamic substances and effects of Yiqihuayu Decoction for acute ischemic stroke; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yiqihuayu Decoction

Snippet

Sponsor: Ying Gao | Conditions: Ischemic Stroke, Acute | Phase 2, Phase 3 | Status: UNKNOWN